Andrew John Hugh MacIntyre Sims - 01 Oct 2026 Form 4 Insider Report for CERENOME, INC. (CNSY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 Oct 2026, 08:00:07 UTC
Prior SEC filing
01 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Sims
Filing notes and source

Key filing fact

Andrew John Hugh MacIntyre Sims filed Form 4 for CERENOME, INC. (CNSY) on 01 Oct 2026.

Key facts

  • This page summarizes Andrew John Hugh MacIntyre Sims's Form 4 filing for CERENOME, INC. (CNSY).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 01 Oct 2026, 08:00.

Change

  • Previous filing in this sequence was filed on 01 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001802687 Primary reporting owner

Sims Andrew John Hugh MacIntyre

Relationship
Chief Financial Officer
Address
C/O PLUS THERAPEUTICS INC., 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON
Signature
/s/ Andrew Sims
Signature date
01 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNSY transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,533
Change %
+15%
Price
$0.000000*
Shares after
11,474
Date
01 Oct 2026
Ownership
Direct
Footnotes
F1, F2
CNSY transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,165
Change %
+10%
Price
$0.000000*
Shares after
12,639
Date
01 Oct 2026
Ownership
Direct
Footnotes
F1, F3
CNSY transaction

Common Stock

Options Exercise

Transaction value
Shares
+287
Change %
+2.3%
Price
$0.000000*
Shares after
12,926
Date
01 Oct 2026
Ownership
Direct
Footnotes
F1, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNSY transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,533
Change %
-5.7%
Price
$0.000000*
Shares after
25,537
Date
01 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,533
Exercise price
$0.000000
Footnotes
F2
CNSY transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,165
Change %
-4.6%
Price
$0.000000*
Shares after
24,372
Date
01 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,165
Exercise price
$0.000000
Footnotes
F3
CNSY transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-287
Change %
-1.2%
Price
$0.000000*
Shares after
24,085
Date
01 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
287
Exercise price
$0.000000
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.

Footnote F2

Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on October 1, 2025.

Footnote F3

Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on April 1, 2026.

Footnote F4

Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on July 1, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .